Research and Practice in Thrombosis and Haemostasis
Publisher: Elsevier · ISSN 2475-0379 · 80 articles
- Abnormal lipid profiles are associated with markers of impaired fibrinolysis in patients with cirrhosis
- Association of the sarcopenia index based on the serum creatinine to cystatin C ratio and genetic risk with venous thromboembolism: a population-based cohort study
- A screening assay for type 2B von Willebrand factor variants using an enzyme-linked immunosorbent assay based on recombinant wild-type glycoprotein Ib and ristocetin
- Clinical significance of symptomatic and incidental venous thromboembolism in patients with cancer treated with apixaban
- Long-term outcomes of antithrombotic treatment for retinal vein occlusion
- Bleeding events in people with hemophilia B on prophylactic factor IX treatment: a systematic review and meta-analysis
- Evolutionary constraint and population variation across coagulation genes
- Prevalence of qualitative platelet disorders in adolescents and young adults with heavy menstrual bleeding: a single center experience
- Treatment patterns and safety outcomes after splenectomy or thrombopoietin receptor agonists as second-line therapy for immune thrombocytopenia: Korean claims-based study
- Reevaluating hypercoagulability in the portal vein and the impact of transjugular intrahepatic portosystemic shunt on platelet activation in cirrhosis
- A buffer-positive serotonin release assay pattern is associated with increased mortality in HIT: a retrospective cohort study
- Correlation of thrombus immune cell composition and clinical outcome in acute ischemic stroke: an MR CLEAN-NO IV substudy
- Risk of cancer following venous thromboembolism in patients with a history of stroke: a population-based cohort study
- Peri-interventional use of rondaptivon pegol (BT200) in thrombocytopenic patients with type 2B von Willebrand disease with implications for wound healing and therapy for acute bleeding
- Splenectomy corrects bleeding phenotype in gray platelet syndrome with a novel NBEAL2 variant
- AngioJet rheolytic thrombectomy under superior vena cava filter protection for acute upper extremity deep vein thrombosis in patients with cancer: a single-center, retrospective analysis
- A targeted mass spectrometric assay for quantitative detection of fibrinogen in plasma
- Identifying the international need for Antithrombotic Stewardship in perioperative anticoagulation management
- Risk of severe abnormal uterine bleeding in Korean women initiating direct oral anticoagulants: a nationwide population-based cohort study
- Activation of coagulation by trypsin
- Targeted long-read sequencing identifies a novel 1.3 kb FGG deletion associated with variable bleeding and thrombotic phenotypes in hypofibrinogenemia
- Rapid plasma-based screening of fibrinolytic activation in trauma: a single-center observational cohort study
- Assay or astray? discrepancies in efanesoctocog alfa monitoring
- Multiplex complement profiling uncovers complement activation signatures in microvascular manifestations of antiphospholipid syndrome
- Biomechanical viscoelastic properties in leg muscles of people with hemophilia: a case control study
- Management of bleeding and nonelective invasive procedures in patients receiving direct oral anticoagulants (DOACs): a 5-year single-center observational study
- Alternative Lys277 cleavage modulates tissue plasminogen activator processing and fibrinolysis
- Enabling artificial intelligence-driven blind joint ultrasound self-scans in hemophilia: an annotation protocol
- Characteristics of pediatric central venous catheter malfunction and subsequent catheter-related deep vein thrombosis
- Interassay and interlaboratory comparison of von Willebrand factor antigen as a diagnostic and prognostic biomarker in advanced chronic liver disease